FDA Inspection
Brio Pharmaceuticals IncBrio Pharmaceuticals Inc – FDA Inspection, Jan 12, 2012
Record Details
This FDA Inspection record concerns Brio Pharmaceuticals Inc, with an inspection on January 12, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Brio Pharmaceuticals Inc
- Inspection Date
- January 12, 2012
- Product Type
- Drugs
View Company Profile
ID · d805e387-fb22-4174-99a9-85d8aeb8ef55
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 762066
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Brio Pharmaceuticals Inc
10| Date | Classification | Office | Project area |
|---|---|---|---|
| June 19, 2026 | Not classified | Dallas District Office | |
| February 27, 2026 | VAI | Dallas District Office | Drug Quality Assurance |
| July 11, 2019 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| October 3, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2017 | Not classified | Dallas District Office | Drug Quality Assurance |
Other documents for Brio Pharmaceuticals Inc
- FDA Inspection 1323564 - 2026-06-19
- FDA Inspection 1304746 - 2026-02-27
- FDA Inspection 1096432 - 2019-07-11
- FDA Inspection 1067624 - 2018-10-03
- FDA Inspection 1011466 - 2017-04-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.